Dividend Channel
www.valueforum.com/7/
Free Dividend Newsletter
Gain access to weekly reports featuring our proprietary DividendRank lists broken down by the top ranked stocks in each of 18 categories/industry groupings.

Dividend Channel Recommends: ValueForum.com

Dividend Channel presents ValueForum, the best place to discuss dividend stocks with serious value and income investors.

PARTNER NEWS:

Mon, Jun 14, 8:26 AM, Zacks
J&J (JNJ) Gets FDA Nod for 10M COVID Vaccines, Discards Many
J&J (JNJ) gets authorization for two batches of COVID-19 vaccine doses manufactured at Baltimore facility but the FDA discards several others. Europe and Canada stop the rollout of some batches of the vaccine.

Mon, Jun 14, 8:23 AM, Zacks
AstraZeneca (AZN) COVID-19 Jab's New Side Effect Stated by EMA
The PRAC of the European Medicines Agency (EMA) has advised against giving AstraZeneca's (AZN) Vaxzevria COVID-19 vaccine to people with a history of capillary leak syndrome, a rare blood disorder.

Dividend Discussion Forum | Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2021, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.